🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study (Dual IV thrombolysis Approach (DIVA) study) is t...
Status
Completed
Location
Centre Hospitalier Sud Francilien
Start Date
2023-05-17
Trial ID
NCT05809921
Treatments Being Tested
Proximal Middle Cerebral Artery (MCA) occlusions constitute the most severe...
Status
Withdrawn
Location
Multiple Locations
Start Date
2016-07
Trial ID
NCT02338466
Treatments Being Tested
Patients presenting to the emergency department with an acute ischemic stro...
Status
Recruiting
Location
Bankstown-Lidcombe Hospital
Start Date
2021-11-29
Trial ID
NCT05105633
Treatments Being Tested
This study is open to Chinese adults who had an ischaemic stroke, which mea...
Status
Completed
Location
Inner Mongolia Baogang Hospital
Start Date
2021-06-22
Trial ID
NCT04915729
Treatments Being Tested
This randomized, double-blind, placebo-controlled phase III clinical trial ...
Status
Recruiting
Location
Wuhan No. 1 Hospital
Start Date
2025-10-21
Trial ID
NCT06987305
Treatments Being Tested
This study looks at whether stroke patients who take FXa inhibitors (a type...
Status
Recruiting
Location
Dept. of Medicine, Baerum Hospital
Start Date
2025-03-14
Trial ID
NCT06878066
Treatments Being Tested
Despite being the standard pharmacological reperfusion therapy for acute is...
Status
Recruiting
Location
Yu Cui
Start Date
2026-03-25
Trial ID
NCT07375953
Treatments Being Tested
While intravenous thrombolysis (IVT) within 4.5 hours is the standard medic...
Status
Recruiting
Location
Lu Wang
Start Date
2026-03-25
Trial ID
NCT07375966
Treatments Being Tested
Human urinary kallidinogenase (HUK) is a tissue kallikrein extracted from h...
Status
Recruiting
Location
Department of Neurology, General Hospital of Northern Theater Command
Start Date
2026-01-20
Trial ID
NCT07283159
Treatments Being Tested
Study purpose: A multicenter, prospective, randomized, open-label, blinded...
Status
Not Yet Recruiting
Location
the First Affiliated Hospital with Nanjing Medical University
Start Date
2026-07-01
Trial ID
NCT07668323